Wedbush Initiates Coverage of Janux Therapeutics (JANX) with Outperform Recommendation

Fintel reports that on April 6, 2023,
Wedbush
initiated coverage of Janux Therapeutics (NASDAQ:JANX) with
a Outperform recommendation.

admin